The East Africa Consortium for human papillomavirus and cervical cancer in women living with HIV/AIDS

被引:6
作者
Tong, Y. [1 ]
Orang'o, E. [2 ]
Nakalembe, M. [3 ]
Tonui, P. [2 ]
Itsura, P. [2 ]
Muthoka, K. [2 ]
Titus, M. [4 ]
Kiptoo, S. [2 ]
Mwangi, A. [2 ]
Ong'echa, J. [5 ]
Tonui, R. [2 ]
Odongo, B. [2 ]
Mpamani, C. [3 ]
Rosen, B. [6 ]
Moormann, A. [7 ]
Cu-Uvin, S. [8 ]
Bailey, J. A. [8 ]
Oduor, C., I [8 ]
Ermel, A. [1 ]
Yiannoutsos, C. [1 ]
Musick, B. [1 ]
Sang, E. [9 ]
Ngeresa, A. [9 ]
Banturaki, G. [3 ]
Kiragga, A. [3 ]
Zhang, J. [10 ]
Song, Y. [10 ]
Chintala, S. [1 ]
Katzenellenbogen, R. [1 ]
Loehrer, P. [1 ]
Brown, D. R. [1 ]
机构
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Moi Univ, Eldoret, Kenya
[3] Makerere Univ, Infect Dis Inst, Kampala, Uganda
[4] Maseno Univ, Kisumu, Kenya
[5] Kenya Govt Med Res Ctr, Eldoret, Kenya
[6] Beaumont Gynecol Oncol, Royal Oak, MI USA
[7] Univ Massachusetts, Chan Med Sch, Worcester, MA 01605 USA
[8] Brown Univ, Providence, RI 02912 USA
[9] AMPATH, Eldoret, Kenya
[10] Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA
基金
美国国家卫生研究院;
关键词
HPV; HIV; Kenya; Uganda; cervical cancer; VISUAL INSPECTION; ACETIC-ACID; INFECTED WOMEN; PAP-SMEAR; IMMUNODEFICIENCY; RISK; PERSISTENCE; PREVENTION; CYTOLOGY; POPULATION;
D O I
10.1080/07853890.2022.2067897
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The East Africa Consortium was formed to study the epidemiology of human papillomavirus (HPV) infections and cervical cancer and the influence of human immunodeficiency virus (HIV) infection on HPV and cervical cancer, and to encourage collaborations between researchers in North America and East African countries. To date, studies have led to a better understanding of the influence of HIV infection on the detection and persistence of oncogenic HPV, the effects of dietary aflatoxin on the persistence of HPV, the benefits of antiretroviral therapy on HPV persistence, and the differences in HPV detections among HIV-infected and HIV-uninfected women undergoing treatment for cervical dysplasia by either cryotherapy or LEEP. It will now be determined how HPV testing fits into cervical cancer screening programs in Kenya and Uganda, how aflatoxin influences immunological control of HIV, how HPV alters certain genes involved in the growth of tumours in HIV-infected women. Although there have been challenges in performing this research, with time, this work should help to reduce the burden of cervical cancer and other cancers related to HIV infection in people living in sub-Saharan Africa, as well as optimized processes to better facilitate research as well as patient autonomy and safety. KEY MESSAGES The East Africa Consortium was formed to study the epidemiology of human papillomavirus (HPV) infections and cervical cancer and the influence of human immunodeficiency virus (HIV) infection on HPV and cervical cancer. Collaborations have been established between researchers in North America and East African countries for these studies. Studies have led to a better understanding of the influence of HIV infection on the detection and persistence of oncogenic HPV, the effects of dietary aflatoxin on HPV detection, the benefits of antiretroviral therapy on HPV persistence, and the differences in HPV detections among HIV-infected and HIV-uninfected women undergoing treatment for cervical dysplasia by either cryotherapy or LEEP.
引用
收藏
页码:1202 / 1211
页数:10
相关论文
共 43 条
  • [1] Bouassa RSM, 2017, MED SANTE TROP, V27, P16, DOI [10.1684/mst.2016.0648, 10.1684/mst.2017.0648]
  • [2] International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019
    Chammartin, Frederique
    Ostinelli, Cam Ha Dao
    Anastos, Kathryn
    Jaquet, Antoine
    Brazier, Ellen
    Brown, Steven
    Dabis, Francois
    Davies, Mary-Ann
    Duda, Stephany N.
    Malateste, Karen
    Nash, Denis
    Wools-Kaloustian, Kara
    von Groote, Per M.
    Egger, Matthias
    [J]. BMJ OPEN, 2020, 10 (05):
  • [3] Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
    Clifford, GM
    Smith, JS
    Aguado, T
    Franceschi, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 101 - 105
  • [4] Human papillomavirus types in invasive cervical cancer worldwide:: a meta-analysis
    Clifford, GM
    Smith, JS
    Plummer, M
    Muñoz, N
    Franceschi, S
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (01) : 63 - 73
  • [5] Cancer risk in the swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy
    Clifford, GM
    Polesel, J
    Rickenbach, M
    Dal Maso, L
    Keiser, O
    Kofler, A
    Rapiti, E
    Levi, F
    Jundt, G
    Fisch, T
    Bordoni, A
    De Weck, D
    Franceschi, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06): : 425 - 432
  • [6] Du P, 2019, CANCER TREAT RES, V177, P105, DOI 10.1007/978-3-030-03502-0_5
  • [7] A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women
    Ermel, A.
    Tonui, P.
    Titus, M.
    Tong, Y.
    Wong, N.
    Ong'echa, J.
    Muthoka, K.
    Kiptoo, S.
    Moormann, A.
    Hogan, J.
    Mwangi, A.
    Cu-Uvin, S.
    Loehrer, P. J.
    Orang'o, O.
    Brown, D.
    [J]. BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [8] Longer duration of anti-retroviral therapy is associated with decreased risk of human papillomaviruses detection in Kenyan women living with HIV
    Ermel, Aaron
    Tong, Yan
    Tonui, Phillip
    Orang'o, Omenge
    Muthoka, Kapten
    Wong, Nelson
    Manai, Titus
    Kiptoo, Stephen
    Loehrer, Patrick J.
    Brown, Darron R.
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (13) : 1212 - 1220
  • [9] Ferenczy A, 2003, CAN MED ASSOC J, V169, P431
  • [10] The prevention of cervical cancer in HIV-infected women
    Franceschi, Silvia
    Ronco, Guglielmo
    [J]. AIDS, 2010, 24 (16) : 2570 - 2571